Persistent Transgene Expression Following Intravenous Administration of a Liposomal Complex: Role of Interleukin-10-Mediated Immune Suppression
Open Access
- 31 March 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (3) , 318-327
- https://doi.org/10.1016/j.ymthe.2004.01.007
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungsGene Therapy, 2000
- ANALYSIS OF AIR POLLUTION PARTICULATE-MEDIATED OXIDANT STRESS IN ALVEOLAR MACROPHAGESJournal of Toxicology and Environmental Health, Part A, 1998
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993
- Interleukin-10Annual Review of Immunology, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Biological properties of interleukin 10Immunology Today, 1992
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989